TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling Complex  by Hsu, Hailing et al.
Immunity, Vol. 4, 387±396, April, 1996, Copyright 1996 by Cell Press
TNF-Dependent Recruitment of the
Protein Kinase RIP to the TNF Receptor-1
Signaling Complex
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sion of TRADD potently activates distinct signaling cas-Vijay Baichwal, and David V. Goeddel
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The recent discovery that TRADD interacts with
TRAF2 and FADD suggests that TRADD may function
as an adapter to recruit other signaling proteins to
Summary TNFR1 upon TNF stimulation (Hsu et al., 1996). TRAF2
was originally characterized as a TNFR2-associating
The death domain of tumor necrosis factor (TNF) re- protein (Rothe et al., 1994) that is required for NF-kB
ceptor-1 (TNFR1) triggers distinct signaling pathways activation by TNFR2 (Rothe et al., 1995). The recruitment
leading to apoptosis and NF-kB activation through of TRAF2 also appears to be required for certain TNFR1
its interaction with the death domain protein TRADD. signals, because overexpression of a dominant negative
Here, we show that TRADD interacts strongly with version of TRAF2blocks TNFR1-mediated NF-kB activa-
tion (Hsu et al., 1996). However, TRAF2 does not appearRIP, another death domain protein that was shown
to be involved in the TNFR1 signaling cascade leadingpreviously to associate with Fas antigen.We also show
to apoptosis. FADD (MORT1) is a death domain proteinthat RIP is a serine±threonine kinase that is recruited
that was originally isolated based on its interaction withby TRADD to TNFR1 in a TNF-dependent process.
Fas (Boldin et al., 1995a;Chinnaiyan et al.,1995), anotherOverexpression of the intact RIP protein induces both
member of the TNF receptor family (Smith et al., 1994).NF-kB activation and apoptosis. However, expression
FADD can induce apoptosis when overexpressed (Bol-of the death domain of RIP induces apoptosis, but
din et al., 1995a; Chinnaiyan et al., 1995; Hsu et al.,potently inhibits NF-kB activation by TNF. These re-
1996). As FADD interacts strongly with TRADD (Hsu etsults suggest that distinct domains of RIP participate
al., 1996), it may also participate in TNFR1 signaling. Inin the TNF signaling cascades leading to apoptosis
support of this notion, an N-terminal truncation mutantand NF-kB activation.
of FADD acts as a dominant negative inhibitor of TNF-
mediated apoptosis, but not NF-kB activation (Hsu et
al., 1996; Chinnaiyan et al.,1996). Together, these resultsIntroduction
prompted the conclusion that the TNFR1±TRADD com-
plex activates two distinct signaling cascades.Tumor necrosis factor (TNF) exerts its diverse biological
Although several lines of evidence support a role forproperties by binding to and activating distinct cell sur-
TRAF2 in TNF signaling leading to NF-kB activation, itsface receptors of z55 kDa (TNF receptor-1 [TNFR1]) and
mechanism of signaling remains unclear. It is knownz75 kDa (TNFR2) (reviewed by Tartaglia and Goeddel,
that NF-kB activation requires phosphorylation of the1992; Rothe et al., 1992). The cytoplasmic domains of
NF-kB inhibitor protein, IkB, at specific serine residuesthese two receptors, which are unrelated in primary
(Brown et al., 1995). This phosphorylation targets IkBamino acid sequence (Dembic et al., 1990; Lewis et al.,
for degradation by the proteasome (Palombella et al.,1991; Goodwin et al., 1991), initiate intracellular signaling
1994), releasing NF-kB for migration to the nucleuspathways that are largely independent. The results of
where it activates a battery of genes involved in thegene knockout studies and experiments using receptor-
inflammatory response (reviewed by Thanos andspecific agonist antibodies have demonstrated that
Maniatis, 1995; Finco and Baldwin, 1995). Therefore,TNFR1 is the major signaling receptor for TNF (reviewed
TNF-mediated NF-kB activation is thought to require
by Vandenabeele et al., 1995). Yet TNFR1 and TNFR2
the action of an IkB-directed protein kinase. Although
do have some overlap in the cellular responses they
TNF is known to activate many cytosolic kinases (re-
elicit. For example, both receptors are able to trigger viewed by Vandenabeele et al., 1995), an inducible IkB
two of the major functions of TNF, activation of the kinase has not yet been identified. One likely candidate
transcription factor NF-kB (Wiegmann et al., 1992; for a kinase involved in the TNF-mediated NF-kB activa-
Lñgreid et al., 1994; Rothe et al., 1994; Hsu et al., 1995) tion cascade is a TNF-dependent serine kinase activity
and induction of cell death (Tartaglia et al., 1993b; Grell that associates with immunoprecipitates of TNFR1
et al., 1993). However, TNFR1 is the dominant receptor, (VanArsdale and Ware, 1994). However, the molecular
as TNFR2 can activate these two responses in only a identity of this kinase has not been resolved.
very limited number of cell lines. Like TNFR1, the Fas antigen contains a death domain
How TNFR1 transduces signals is now beginning to and can signal apoptosis (reviewed by Nagata and
be deciphered at the molecular level. A death domain Golstein, 1995). Two proteins, RIP (Stanger et al., 1995)
of approximately 80 aa near the C terminus of TNFR1 and FADD (Boldin et al., 1995a; Chinnaiyan et al., 1995),
is essential for signaling apoptosis and NF-kB activation that interact with the death domain of Fas have been
(Tartaglia et al., 1993a; Hsu et al., 1995). We recently identified by yeast two-hybrid cloning. Both of these
identified TRADD, a 34 kDa cytoplasmic protein that proteins contain C-terminal death domains and induce
also contains a C-terminal death domain and associates programmed cell death when overexpressed. Further-
more, RIP was also shown to interact with TNFR1 inwith the death domain of TNFR1 (Hsu et al., 1995) in a
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yeast two-hybrid assays. RIP contains an N-terminal
region of z300 aa that is homologous to both serine/
threonine and tyrosine protein kinases. Thus, in contrast
with TRADD, FADD, and TRAF2, RIP may have enzy-
matic activity. However, Stanger et al. (1995) were un-
able to demonstrate protein kinase activity specified by
the RIP protein. Moreover, they found that a RIP mutant
lacking the kinase domain was still able to induce cell
death (Stanger et al., 1995).
In an effort to isolate additional components of the
TNFR1 signaling complex, we searched for TRADD-in-
teracting proteins. This screen resulted in the identifica-
tion of RIP as a protein that associates strongly with
TRADD. In addition to inducing apoptosis, we found that
overexpression of RIP also results in activation of NF-
Figure 1. Predicted Amino Acid Sequence of Human RIP
kB. The death domain of RIP alone can both induce
The amino acid sequence of human RIP deduced from the cDNAapoptosis and block NF-kB activation by TNF-R1. Fur-
sequence is shown. Residues identical to those found in murine RIP
thermore, we demonstrated that RIP is an active serine/ are shaded. The kinase (amino acids 1±300) and death (amino acids
threonine kinase that is rapidly recruited to TNFR1 fol- 589±671) domains are indicated by brackets.
lowing TNF treatment. These results demonstrate that
RIP is a part of the active TNFR1 complex and suggest
were cotransfected into human embryonic kidney 293that different domains of RIP may be involved in trans-
cells. Cell extracts were immunoprecipitated with poly-ducing TNFR1±TRADD signals for programmed cell
clonal antibodies directed against the N terminus ofdeath and NF-kB activation.
TRADD and coprecipitating RIP was detected by West-
ern blotting with an anti-FLAG monoclonal antibody
(MAb) (Figure 2A). We also examined the ability of RIPResults
to interact with TNFR1, Fas, and TNFR2 in 293 cells.
Both TNFR1 and Fas interacted weakly with RIP in thisIdentification of RIP as a TRADD-Interacting Protein
A previous two-hybrid screen for TRADD-interacting assay, whereas TNFR2 failed to interact (Figure 2A).
proteins resulted in the identification of TNFR1, TRAF2,
and FADD (Hsu et al., 1996). TRAF2 interacts with the RIP Interacts with TRAF Proteins
We recently demonstrated that TRADD interacts withN-terminal part of TRADD and appears coupled to NF-
kB activation pathways, whereas FADD interacts with TRAF1, TRAF2, and TRAF3 and can recruit TRAFs to
the TNFR1 complex (Hsu et al., 1996). Since RIP andthe death domain of TRADD and may be coupled to the
apoptosis pathway (Hsu et al., 1996). Since overexpres- TRADD interact, we decided to examine whether RIP
might also interact with TRAFs. The results of coimmu-sion of the death domain of TRADD alone is sufficient
to trigger NF-kB activation (Hsu et al., 1995), we rea- noprecipitation experiments demonstrated that RIP
specifically interacts with all three TRAF proteins (Figuresoned that this domain might be coupled to downstream
signaling molecules in addition to FADD. Therefore, the 2B). The specific interactions detected inall of the above
immunoprecipitation assays were confirmed in yeastC-terminal 118 aa of TRADD were used as bait in a yeast
two-hybrid screen of a mouse peripheral lymph node two-hybrid interaction assays (data not shown).
cDNA library. As expected, many of the cDNA clones
obtained were found to encode portions of TNFR1 and Characterization of RIP Deletion Mutants
Deletion mutants of RIP were constructed and analyzedTRADD. However, we also isolated two cDNAs that en-
code the C-terminal z100 aa of RIP, a protein initially for their ability to interact with TRADD and TRAF2 in
cotransfection assays (Figure 3). All RIP mutants con-described based on its interaction with the intracellular
domain of Fas (Stanger et al., 1995). taining a death domain (amino acids 559±671) were able
to associate with TRADD, confirming that RIP andMurine RIP is a 656 aa protein that contains an
N-terminal kinase homology domain and a C-terminal TRADD interact via their respective death domains. RIP
contains two domains that can independently interactdeath domain (Stanger et al., 1995). The sizes of the
two-hybrid clones we obtained suggest that the death with TRAF2 as RIP mutants containing either a kinase
domain (amino acids 1±300) or an intermediate domaindomains of TRADD and RIP directly interact. To perform
functional assays we isolated a full-length human RIP (amino acids 301±558) coimmunoprecipitated with
TRAF2. Thus, RIP appears to use different domains tocDNA by screening an umbilical vein endothelial cell
cDNA library. Human RIP is a 671 aa protein having a associate with TRADD and TRAF2, two proteins known
to be involved in TNFR1-mediated signal transductionpredicted molecular mass of z76 kDa. Overall, human
RIP is 68% identical to murine RIP with the greatest (Hsu et al., 1995, 1996).
The RIP deletion mutants were overexpressed andsimilarity occurring in the death domain (Figure 1).
To confirm that TRADD and RIP interact in mammalian analyzed for their ability to induce apoptosis. The death
domain of RIP was both necessary and sufficient for thecells, we performed a coimmunoprecipitation assay. Ex-
pression vectors encoding TRADD and full-length hu- induction of apoptosis in either HeLa or 293 cells (Figure
3). Since RIP interacts with TRADD and TRAF2, twoman RIP modified tocontain an N-terminalFLAG epitope
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proteins that can activate NF-kB when overexpressed
(Hsu et al., 1995; Rothe et al., 1995), we also asked
whether RIP overexpression could lead to NF-kB activa-
tion. RIP overexpression in 293 cells potently activated
an NF-kB-dependent reporter gene. The intermediate
domain of RIP was required for this activity, which was
enhanced by the presence of its kinase and death do-
mains (Figure 3).
The Death Domain of RIP Blocks
TNF-Mediated NF-kB Activation
Since overexpression of either the kinase (amino acids
1±300) or death (amino acids 559±671) domain of RIP
does not result in activation of NF-kB (Figure 3), we
tested whether these individual domains might act as
dominant negative inhibitors of NF-kB activation sig-
naled by TNFR1. These experiments were performed
using 293 cells, as TNF activates NF-kB exclusively
through TNFR1 in these cells (Rothe et al.,1995). Expres-
sion of the RIP kinase domain had no effect (data not
shown), whereas expression of the RIP death domain
dramatically inhibited TNF-induced NF-kB activation
(Figure 4). In a dose±response experiment, transfection
of low levels (0.1 mg) of RIP(559±671) expression vector
was sufficient to block NF-kB activation triggered by
TNF. In contrast, even high level expression of RIP(559±
671) did not inhibit NF-kB activation signaled by interleu-
kin-1 (IL-1; Figure 4). Similar results were obtained inFigure 2. RIP Interactions in Mammalian Cells
HeLa cells (data not shown). These results demonstrate(A) Coimmunoprecipitation of RIP with TRADD, TNFR1, and Fas.
293 cells (2 3 106) were transfected with the indicated combinations that RIP(559±671) is a specific dominant negative inhibi-
of expression vectors for TRADD, TNFR1, TNFR2, Fas, and FLAG tor of the TNF-mediated NF-kB activation pathway and
epitope-tagged RIP (6 mg each). Extracts were prepared and immu- that RIP may be required for signaling NF-kB activation
noprecipitated 20 hr later with preimmune serum (lanes 1, 3, 5, and
by TNFR1.7) or rabbit antisera against TRADD (lane 2), TNFR1 (lane 4), TNFR2
(lane 6), or Fas (lane 8). Coprecipitating FLAG±RIP was detected by
immunoblot analysis with anti-FLAG MAb. TRADD Recruits RIP to TNFR1
(B) Coimmunoprecipitation of RIP with TRAF proteins. 293 cells RIP can directly associate with TNFR1, but this interac-
were transfected with the indicated combinations of expression tion is quite weak, whether assayed by yeast two-hybrid
vectors for myc±RIP, FLAG±TRAF1, FLAG±TRAF2, and HA±TRAF3
assays (Stanger et al., 1995) or mammalian cell coimmu-(6 mg each). Lysates were immunoprecipitated with control mouse
noprecipitation assays (see Figure 2). However, sinceIgG (lanes 1, 3, and 5) or MAbs against either the FLAG (lanes 2 and
4) or HA (lane 6) epitope. Coprecipitating myc±RIP was detected TRADD interacts strongly with both TNFR1 (Hsu et al.,
by immunoblot analysis with anti-myc MAb. Positions of molecular 1995) and RIP (see Figure 2), we considered the possibil-
mass standards (in kilodaltons) are shown. ity that TRADD might recruit RIP toTNFR1 through oligo-
merization of death domains. 293 cells were transfected
Figure 3. Functional Analysis of RIP Deletion
Mutants
The horizontal bars represent the sequence
of RIP, with kinase (open), intermediate
(striped), and death (closed) domains indi-
cated. The amino acids contained in each
deletion mutant are indicated. Dotted lines
refer to internally deleted amino acids. Inter-
actions of the RIP mutants with TRADD and
TRAF2 were determined by coimmunopreci-
pitation assays from 293 cells. NF-kB activa-
tion assays were performed by cotransfec-
tion of 293 cells with RIP deletion mutant
expression plasmids and the NF-kB reporter
plasmid pELAM±luc (Hsu et al., 1995). The
increases in luciferase levels relative to 293
cells transfected with a control vector are
shown as follows. Three pluses indicate greater than 50-fold; two pluses indicate greater than 20-fold; one plus indicates greater than 6-fold,
and minus indicates less than 1.5-fold. Apoptosis assays were performed by transient transfection of HeLa and 293 cells as described in
Experimental Procedures. Plus indicates a significant decrease in the number of blue-staining HeLa cells and apoptotic morphological changes
of 293 cells. Minus indicates no significant changes in number of blue-staining HeLa cells or morphology of 293 cells.
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cell death when overexpressed (Ala207±209, Ala245±
247, and Ala269±271), were also effective at recruiting
RIP to TNFR1. However, mutations in TRADD that abro-
gated NF-kB activation and apoptosis (Ala235±237,
Ala252±255, and Ala296±299) failed to recruit RIP to
TNFR1. Thus, a strong correlation exists between RIP-
recruiting ability of TRADD mutants and their capacity
for inducing apoptosis and NF-kB activation. These re-
sults provide further evidence that RIP is involved in
TNFR1 signal transduction.
TNFR1±TRADD±TRAF2±RIP Complex
TRAF2 can be recruited to the TNFR1 complex through
its interaction with the N-terminal domain of TRADD
(Hsu et al., 1996). Since RIP interacts with both TRAF2
and TRADD, albeit through distinct domains, we exam-
ined whether RIP expression might interfere with the
recruitment of TRAF2 to the TNFR1 complex (Figure 6).
Increasing ectopic expression of RIP in 293 cells did
not inhibit TRAF2 recruitment. Nor did the presence of
TRAF2 prevent recruitment of RIP. Rather, RIP recruit-Figure 4. The RIP Death Domain Specifically Inhibits TNF-Induced
NF-kB Activation ment to the receptor complex increased with increasing
expression levels. Thus, TRADD appears able to recruit293 cells (2 3 105) were transfected with 1 mg of pELAM±luc reporter,
0.5 mg pRSV±b-gal, 0.5 mg pRK5±crmA, the indicated amounts of TRAF2 and RIP simultaneously to TNFR1 via its N-termi-
RIP(559±671) expression vector, and enough pRK5 control vector nal TRAF-interacting domain and C-terminal death do-
to give a total of 5.2 mg DNA. After 36 hr of transfection, cells were main, respectively.
treated for 6 hr with 20 ng/ml of either TNF or IL-1. Values represent
luciferase activities, normalized for b-gal expression, relative to the
same cells without cytokine treatment and are shown as mean 6 Association of RIP with TNFR1 Is TNF DependentSEM for representative experiments performed in duplicate.
TRADD recruits RIP toTNFR1 when all three proteins are
overexpressed (see Figure 5A). However, under these
conditions TNFR1 oligomerizes in the absence of TNF
with various combinations of expression vectors that treatment (Boldin et al., 1995b; Hsu et al., 1995). We
direct the synthesis of TNFR1, TRADD, and RIP. Cell recently demonstrated in human U937 cells that the
extracts were immunoprecipitated with an antibody interaction of endogenous TRADD with TNFR1 is depen-
against the extracellular domain of TNFR1 and copreci- dent on TNF-induced receptor aggregation (Hsu et al.,
pitating proteins were detected by Western blotting (Fig- 1996). This result suggests that if RIP were to associate
ure 5A). This analysis confirmed that the TNFR1±TRADD with the TNFR1 complex in cells, then this interaction
interaction is considerably stronger than the relatively should likewise be TNF dependent. To test whether RIP
weak TNFR1±RIP interaction. When these experiments is a component of the TNFR1 signaling complex, we
were performed using cells that coexpressed TNFR1, immunoprecipitated endogenous TNFR1 from lysates
TRADD, and RIP, the coimmunoprecipitation of RIP with of TNF-treated and TNF-untreated U937 cells. Copreci-
TNFR1 was greatly enhanced. Furthermore, the death pitating proteins were tested for the presence of RIP
domain of TRADD (amino acids 195±312) alone was suf- by Western blotting with an anti-RIP polyclonal antise-
ficient for this enhanced recruitment of RIP to TNFR1 rum. RIP coprecipitated with TNFR1 only in lysates pre-
(Figure 5A). These results suggest that TRADD can serve pared from TNF-treated cells (Figure 7). Therefore, both
as an adapter protein to recruit RIP to the TNFR1 com- TRADD and RIP are recruited to TNFR1 in a TNF-depen-
plex and that the three death domains can oligomerize dent process.
to form a complex that is likely to be trimeric (or higher
order) in nature.
Deletion mutagenesis experiments have defined a re- RIP Is a Serine±Threonine Protein Kinase
VanArsdale and Ware (1994) have demonstrated thegion of 111 aa near the C terminus of TRADD that medi-
ates self-association, interaction with TNFR1, and that TNF-dependent association with TNFR1 of a serine pro-
tein kinase activity in U937 cells. Furthermore, serinecan induce apoptosis and NF-kB activation when over-
expressed (Hsu et al., 1995). Subsequently, alanine scan phosphorylation is known to be required for activation
of NF-kB by TNF (Beg and Baldwin, 1993). Since RIPmutagenesis performed on the C-terminal 118 aa of
TRADD has identified residues throughout the death has a kinase homology domain and is recruited to the
TNFR1 complex, we asked whether RIPspecifies proteindomain that are required for these properties (A. Park
and V. B., unpublished data). We examined several of kinase activity. RIP containing an N-terminal myc epi-
tope tag was expressed in 293 cells and immunoprecipi-the alanine substitution mutants for their ability to recruit
RIP to TNFR1 (Figure 5B). Wild-type TRADD(195±312) tated with an anti-myc MAb. An in vitro kinase assay
was performed on the immune complex. A 32P-labeledand mutants capable of activating NF-kB and inducing
TNFR1±RIP Signaling Complex
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Figure 5. TRADD Recruits RIP to TNFR1
(A) The death domain of TRADD is sufficient to recruit RIP to TNFR1. 293 cells (2 3 106/100 mm plate) were transfected with the indicated
combinations of expression plasmids (4 mg each) for TNFR1, myc±RIP, myc±TRADD (lanes 1, 2), untagged TRADD (lanes 5, 6), and C-terminal
death domain of TRADD (lanes 7, 8). Control vector pRK5 plasmid was added where necessary to reach the same final DNA amount. After
20 hr, cell extracts were immunoprecipitated with preimmune serum (lanes 1, 3, 5, and 7) or rabbit polyclonal antibody against the extracellular
domain of TNFR1 (lanes 2, 4, 6, and 8). Coprecipitating myc±TRADD and myc±RIP were detected by immnoblot analysis with an anti-myc
MAb. RIP expression levels were similar in all samples (data not shown). Positions of molecular mass standards (in kilodaltons) are shown.
(B) NF-kB activation and RIP recruitment by TRADD death domain mutants. 293 cells were transfected with 4 mg of expression vectors
encoding TNFR1, FLAG±RIP, and the indicated TRADD death domain mutants. TRADD(195±312) is referred to as wild type and the mutants
are indicated by amino acid positions of corresponding alanine substitutions. Lysates were immunoprecipitated with preimmune serum (lanes
1, 3, 5, 7, 9, 11, 13, and 15) or rabbit anti-human TNFR1 antiserum (lanes 2, 4, 6, 8, 10, 12, 14, and 16). Coprecipitating FLAG±RIP was detected
by immunoblot analysis with an anti-FLAG MAb. The expression levels of RIP and the various TRADD mutants were similar in all samples
(data not shown). NF-kB activation assays were performed following cotransfection of 293 cells with TRADD death domain mutants and the
NF-kB reporter plasmid pELAM±luc. Data are shown as fold increase in luciferase levels relative to vector transfected 293 cells, and are
averages for an experiment in which each transfection was performed in duplicate. Positions of molecular mass standards (in kilodaltons)
are shown.
band of approximately 75±80 kDa was observed follow- Discussion
ing SDS±PAGE analysis (Figure 8A). We also expressed
a RIP mutant in which the conserved Lys45 in kinase RIP Is a Component of the TNFR1
Signaling Complexsubdomain II was mutated to Ala. This invariant lysine
interacts with ATP and is essential for the enzymatic The majority of the biological activities of TNF are sig-
naled by TNFR1 (reviewed by Vandenabeele et al., 1995).activity of protein kinases (Hanks and Hunter, 1995). No
kinase activity was observed in immunoprecipitates of The signaling of two important activities, activation of
NF-kB and induction of apoptosis, requires an intactRIPK45A (Figure 8A). These results indicate that RIP is a
protein kinase that becomes autophoshorylated. The TNFR1 death domain (Tartaglia et al., 1993a; Hsu et al.,
1995). TRADD is a death domain protein that associatesresults of phosphoaminoacid analysis performed on the
32P-labeled protein indicate that RIP is a serine± with thedeath domain of TNFR1 following TNF treatment
(Hsu et al., 1995, 1996). Furthermore, TRADD overex-
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the major activity signaled by Fas. The z74 kDa RIP
contains an N-terminal kinase domain, a C-terminal
death domain, and a unique internal region we have
termed intermediate domain. Comparison of the amino
acid sequences of human and murine RIP reveals that
the death (89% identity) and kinase (76% identity) do-
mainsare much more highly conserved than the interme-
diate domain (56% identity), suggesting the latter may
be of less functional importance.
The direct interaction of RIP with Fas appears to be
relatively weak. Similarly, RIP can interact weakly with
TNFR1 in both yeast two-hybrid (Stanger et al., 1995)
and mammalian cell immunoprecipitation assays. The
strong interactions of TRADD with both TNFR1 and RIP
raised the possibility that TRADD might recruit RIP to the
TNFR1 complex. Indeed, in reconstruction experiments
we found that ectopic expression of TRADD results in
Figure 6. Formation of TNFR1±TRADD±TRAF2±RIP Complexes greatly enhanced RIP levels in TNFR1 immune com-
293 cells (2 3 106/100 mm plate) were transfected with the indicated plexes. The death domains of TRADD and RIP were both
combinations of expression plasmids for TNFR1, TRADD, and necessary and sufficient for RIP recruitment to TNFR1.
FLAG±TRAF2 (4 mg each), and 0.32 mg (lanes 5 and 6), 1 mg (lanes
To address the possibility that RIP might be involved in7 and 8), and 3.2 mg (lanes 9 and 10) of FLAG±RIP. After 20 hr, cell
TNFR1 signaling, we asked whether RIP associates withextracts were immunoprecipitated with preimmune serum (lanes 1,
theTNFR1 signalingcomplex under physiological condi-3, 5, 7, and 9) or anti-TNFR1 antiserum (lanes 2, 4, 6, 8, and 10).
Coprecipitating FLAG±TRAF2 and FLAG±RIP were detected by im- tions. As shown previously for TRADD (Hsu et al., 1996),
munoblot analysis with an anti-FLAG MAb. The amounts of TRADD we found that RIP does associate with the TNFR1 com-
and TRAF2 expressed in each sample were similar as determined plex in U937 cells, and that this interaction is TNF de-
by immunoblot analysis of the cell extracts (data not shown). Posi-
pendent.tions of molecular mass standards (in kilodaltons) are shown.
RIP Is Required for NF-kB Activation by TNFR1
pression activates TNFR1 signaling pathways (Hsu et al., The TNF-dependent recruitment of RIP to TNFR1 sug-
1995). To determine how TRADD participates in TNFR1 gested that RIP is involved in TNFR1 signaling. Support-
signaling, we undertook a search for TRADD-interacting ing this premise was the strict correlation between the
proteins. We recently reported that TRADD interacts signaling activity of TRADD mutants and their ability to
with TRAF2and FADD, two signaling proteins implicated recruit RIP to TNFR1. In transient transfection assays
in NF-kB activation and apoptotic pathways, respec- we confirmed earlier work (Stanger et al., 1995) that
tively (Hsu et al., 1996). We also identified RIP as a RIP overexpression induces apoptosis. In addition, we
TRADD-associating protein, suggesting that RIP may found that RIP is a potentactivator of NF-kB, suggesting
also play a role in signal transduction by TNFR1. that RIP may be involved in both of these TNFR1±TRADD
RIP was originally identified in a yeast two-hybrid signaling pathways. Deletional analysis of RIP indicated
screen for Fas-interacting proteins (Stanger et al., 1995). that the poorly conserved intermediatedomain was both
Overexpression of RIP results inprogrammed cell death, required and sufficient for this NF-kB activation. Impor-
tantly, the death domain of RIP not only failed to activate
NF-kB, but was a dominant negative inhibitor of TNF-
mediated NF-kB activation in both HeLa (data not
shown) and 293 cells, two TNFR1-triggered events.
This inhibition of TNFR1 signaling by RIP(559±671) was
both potent and specific, having no effect on NF-kB
activation signaling by IL-1. These results argue strongly
for RIP playing an obligatory role in the signaling of NF-
kB activation by TNFR1.
The Death Domain of RIP Is Required
for Apoptosis
By examining RIP deletion mutants in transfection
Figure 7. Recruitment of RIP to the TNFR1 Complex Is TNF De- assays, we and others (Stanger et al., 1995) have shown
pendent that the kinase domain of RIP is not required for the
U937 cells (2 3 108) were treated with TNF (100 ng/ml) for 15 min induction of cell death. We have also demonstrated that
(lanes 3, 4) or 30 min (lanes 5, 6), or left untreated (lanes 1, 3). Cell the death domain of RIP alone is sufficient to induce
lysates were immunoprecipitated with anti-TNFR1 MAb 985 (lanes apoptosis. RIP mutants lacking the death domain were
2, 4, and 6) or with mouse IgG control antibody (lanes 1, 3, and 5).
unable to induce apoptosis. However, these mutantsCoprecipitating RIP was detected by immunoblot analysis using
also failed to act as dominant negative inhibitors of TNF-rabbit anti-RIP antiserum. Positions of molecular mass standards
(in kilodaltons) are shown. mediated apoptosis (data not shown). These results
TNFR1±RIP Signaling Complex
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Figure 8. RIP Has Serine±Threonine Protein
Kinase Activity
(A) RIP in vitro kinase assay. 293 cells (2 3
106/100 mm plate) were transfected with a
control pRK5 vector (lane 3) or expression
vectors encoding myc-tagged wild-type RIP
(lane 1) or the RIP(K45A) point mutant (lane 2).
Cell extracts were prepared and immunopre-
cipitated 20 hr later with anti-myc MAbs. The
immunoprecipitates were subjected to in
vitro kinase assays (top) or Western blot anal-
ysis with anti-myc antibodies. Positions of
molecular mass standards (in kilodaltons) are
shown.
(B) Phosphoamino acid analysis of RIP. 32P-
labeled RIP prepared as in (A) was acid hy-
drolyzed to individual amino acids, and re-
solved by two-dimensional electrophoresis
on thin-layer chromatography plates. The po-
sitions of phosphoserine, phosphothreonine,
and phosphotyrosine standards are indi-
cated.
suggest that the cell death pathway activated by TNFR1 it is probably through activation of a kinase cascade
that subsequently targets IkB.proceeds through the complex formed by the death
domains of TNFR1, TRADD, and RIP. What is thesignificance of our finding that overexpres-
sion of RIP mutants lacking kinase activity can activateJust how these three death domain proteins activate
this pathway is unclear, but a clue may be provided by NF-kB? One possibility is that the RIP kinase activity is
not required for TNFR1 to signal NF-kB activation, butthe behavior of a fourth death domain protein, FADD.
Overexpression of FADD also leads to cell death, yet is utilized for other signaling cascades or perhaps in
receptor desensitization. However, it is also possibleunlike TNFR1, TRADD, and RIP, the C-terminal death
domain of FADD is not required for this activity (Chinnai- that the kinase activity of RIP is required for NF-kB
activation under normal cellular conditions of low levelyan et al., 1995). In fact, the death domain of FADD is
a dominant negative inhibitor of cell death signaled by expression. This requirement might be bypassed by
overexpression of kinase-deleted mutants. For exam-Fas ligand (Chinnaiyan et al., 1996), TNF (Hsu et al.,
1996; Chinnaiyan et al., 1996), or triggered by overex- ple, deletion mutants containing the RIP intermediate
domain might activate NF-kB as a consequence of theirpression of TNFR1, TRADD (Hsu et al., 1996), and RIP
(data not shown). Therefore, it is possible that FADD is interaction with, and aggregation of, TRAF2, a known
activator of NF-kB (Rothe et al., 1995). Additional experi-a component of the TNFR1 complex that signals cell
death. In this scenario, the N terminus of FADD would ments will clearly be necessary to determine the func-
tion, if any, of the kinase activity of RIP in TNFR1 sig-function to recruit ªdeathº proteins to the complex. This
would be consistent with recent reports on FADD naling.
involvement in assembly and recruitment to Fas of pro-
teins involved in Fas-mediated apoptosis (Kischkel et Is RIP Involved in Fas Signal Transduction?
Even though RIP was discovered via its interaction withal., 1995; Chinnaiyan et al., 1996). Alternatively, overex-
pression of the death domain of FADD may inhibit TNF- Fas, the relative weakness of this interaction calls to
question whether RIP is involved in Fas signaling. Themediated apoptosis by titrating TRADD, RIP, or another
unidentified death protein from the TNFR1 complex. ability of TRADD to enhance the interaction of RIP with
TNFR1 suggests that a similar adaptor may help recruit
RIP to Fas. In transient transfection assays we haveIs RIP Kinase Activity Important
for TNFR1 Signaling? found that FADD serves this role by significantly enhanc-
ing the interaction of RIP with Fas (J. H. and V. B.,The fact that RIP has serinethreonine kinase activity
and is recruited to TNFR1 only after TNF treatment is unpublished data). Therefore, it is possible that the en-
dogenous Fas signaling complex might contain bothsignificant for two reasons. First, it was demonstrated
previously that a TNFR1-associated serine kinase activ- FADD and RIP. This model is conceptually appealing as
Fas, FADD, and RIP can all signal cell death. However,ity can be observed following TNF treatment (VanArs-
dale and Ware, 1994). Whether this activity is due to RIP we (H. H. and D. V. G., unpublished data) and others
(Schulze-Osthoff et al., 1994; Nagata and Golstein, 1995)or other TNFR1-associated protein kinases is unknown
at this time. Second, serine phosphorylation of IkB is have been unable to demonstrate activation of NF-kB
by Fas. This suggests that even if the Fas signalingrequired for activation of NF-kB by TNF (Beg et al., 1993).
However, in our hands IkB does not serve as a substrate complex contains RIP, itmay lack one or more additional
signaling molecules required to effect activation offor RIP (J. H. and V. B. unpublished data). Therefore, if
the kinase activity of RIP is involved in NF-kB activation, NF-kB.
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Transfections and Reporter AssaysConcluding Remarks
The 293 and HtTA-1 (HeLa) cell lines weremaintained in high glucoseBased on the currently available data we propose the
Dulbecco's modified Eagle's medium containing 10% fetal calf se-following speculative model for signal transduction by
rum, 100 mg/ml penicillin G and 100 mg/ml streptomycin (GIBCO).
TNFR1. TNF binding to the extracellular domain of For NF-kB reporter and apoptosis assays, z2 3 105 cells/well were
TNFR1 leads to receptor trimerization (Banner et al., seeded on 6-well (35 mm) dishes. For coimmunoprecipitations,
z2 3 106 cells/well were seeded on 100 mm plates. Cells were1993). Once aggregated, the TNFR1 death domains pro-
transfectedthe following day by thecalcium phosphate precipitationvide a novel molecular interface that interacts specifi-
method (Ausubel et al., 1994). Luciferase reporter assays were per-cally with the death domain of TRADD. Various TRADD-
formed as described (Hsu et al., 1995).interacting proteins such as TRAFs, RIP, and possibly
FADD, are recruited to the TNFR1 complex by virtue of
Coimmunoprecipitation and Western Analysistheir association with TRADD. This complex activates
U937 cells (2 3 108) were grown in RPMI medium containing 10%at least two distinct signaling cascades. In this model,
fetal calf serum and 100 mg/ml each of penicillin G and streptomycin,TRADD and RIP are involved in both apoptosis and NF-
washed in warm phosphate-buffered serum (PBS), and incubated
kB signaling, utilizing distinct domains for both path- for 15 or 30 min in the presence or absence of TNF (100 ng/ml).
ways. In contrast, FADD participation may be limited to Cells were lysed in 1 ml lysis buffer (20 mM Tris [pH 7.5], 150 mM
apoptosis, whereas TRAF2 appears dedicated to the NaCl, 1% Triton, 1 mM EDTA, 30 mM NaF, 2 mM sodium pyrophos-
phate, 10 mg/ml aprotinin, 10 mg/ml leupeptin). Lysates were incu-NF-kB pathway. The actual contribution of each of these
bated with 25 mg of MAb 985 or mouse immunoglobulin g (IgG) for 2proteins in TNFR1 signaling may ultimately have to be
hr at 48C, then mixed with 25 ml of a 1:1 slurry of protein GammaBindresolved through the generation and evaluation of mice
G±Sepharose and incubated for another 2 hr. The Sepharose beads
deficient in the corresponding genes. were washed twice with 1 ml lysis buffer, twice with 1 ml high
salt (1 M NaCl) lysis buffer, and twice more with lysis buffer. The
Experimental Procedures precipitates were fractionated on 10% SDS±PAGE and transferred
to Immobilon-P membrane (Millipore). Subsequent Western analy-
ses were performed as described (Hsu et al., 1995), except that theReagents and Cell Lines
blocking buffer were supplemented with 1% bovine serum albuminRecombinant human TNF and IL-1 were provided by Genentech,
and 3 mg/ml mouse IgG. Transfected 293 cells from each 100 mmIncorporated. The rabbit anti-TNFR1, anti-TNFR2, and anti-Fas anti-
dish were lysed in 1 ml E1A buffer (50 mM HEPES [pH 7.6], 250 mMsera, and the MAb against the myc epitope tag were described
NaCl, 0.1% NP-40, 5mM EDTA). For each immunoprecipitation, 0.5previously (Tartaglia et al., 1991; Wong and Goeddel, 1994; Hsu
ml aliquots of lysates were incubated with 1 ml anti-TRADD, anti-et al., 1995). Polyclonal antibody against the N-terminal portion of
TNFR1, anti-TNFR2, or anti-Fas polyclonal antibody, or 2 ml anti-TRADD was raised against a 35-mer peptide (GQNGHEEWVGSAYLF
FLAG or anti-myc MAb at 48C for at least 1 hr. The lysates wereVESSLDKVVLSDAYAHPQQK) by BABCO (Richmond, California).
mixed with 20 ml of a 1:1 slurry of protein A± or protein G±SepharoseMAb 985 against the extracellular domain of TNFR1 was provided by
(Pharmacia) and incubated for 1 hr. The Sepharose beads wereGenentech, Incorporated. The rabbit anti-RIP antiserum was raised
washed twice with 1 ml E1A buffer, twice with 1 ml high salt (1 Magainst a glutathione S±transferase/RIP fusion protein by Zymed
NaCl) E1A buffer, and twice again with E1A buffer. The precipitatesLaboratories, Incorporated. (South San Francisco, California). The
were fractionated on 10% SDS±PAGE and transferred toMAb against the FLAG epitope was purchased from Kodak Interna-
Immobilon-P membrane (Millipore). Subsequent Western analysestional Biotechnologies, Incorporated. The human 293 embryonic
were performed as described (Hsu et al., 1995).kidney (R. Tjian), human HeLa derivative HtTA-1 (H. Bujard), and
human U937 histiocytic lymphoma (G. Wong) cell lines were ob-
tained from the indicated sources.
In Vitro Kinase Assay and Phosphoamino Acid Analysis
Immunoprecipitates were prepared from transfected 293 cells as
Yeast Two-Hybrid and cDNA Cloning described above and washed twice with 1 ml kinase assay buffer
The plasmid GAL4bd±TRADD (Hsu et al., 1995), which encodes the (20 mM HEPES [pH 7.6], 2 mM DTT, 1mM NaF, and 1 mM sodium
GAL4 DNA-binding domain fused to TRADD(195±312) was used as orthovanadate). The kinase assay was performed at 308C for 30 min
bait in two-hybrid screens (Fields and Song, 1989) of a mouse in 20 ml of kinase assay buffer supplemented with 10 mCi of
peripheral lymph node cDNA library (provided by L. Lasky). The [g-32P]ATP,20 mM b-glycerophosphate, 20 mM PNPP, 20 mMMgCl2,isolation of positive clones and subsequent two-hybrid interaction 20 mM MnCl2, 1 mM benzamidine, 1 mM sodium metabisulfide, 1analyses were carried out as described (Hsu et al., 1995). Full-length mM EDTA, and 100 mM ATP. Reactions were stopped with 20 ml of
RIP cDNAwas obtained by screening human umbilical vein endothe- SDS-sample buffer, boiled for 5 min, and fractionated on SDS±
lial cell cDNA library in lgt11 (provided by Dr. Z. Cao) by standard PAGE. For phosphoamino acid analysis, the gel was transferred to
methods (Sambrook et al., 1989). DNA sequencing was performed Immobilon-P membrane and autoradiographed. The labeled RIP
on an Applied Biosystems model 373A automated DNA sequencer. protein band was cut from the membrane and acid hydrolyzed to
individual amino acids by incubation with 5.7 N HCl for 1 hr at 1108C
Expression Vectors (Coligan et al., 1992). The labeled amino acid residues, together
Mammalian cell expression vectors encoding TNFR1, TNFR2, with unlabeled pSer, pThr, and pTyr standards, were fractionated
TRADD, TRAF1, TRAF2, TRAF3, and crmA have been described by two-dimensional electrophoresis on a thin-layer chromatography
previously (Hsu et al., 1995; Rothe et al., 1995). The control expres- plate. The TLC plate was then stained with 1% ninhybrin, followed
sion plasmid pRK5, the NF-kB reporter plasmid pELAM±luc, and by overnight autoradiography.
pCMV±b-gal were also described previously (Hsu et al., 1995). The
expression vector for Fas was provided by Dr. V. Dixit. FLAG±RIP
or myc±RIP were generated by inserting a BglII±HindIII RIP cDNA Apoptosis Assays
Transfected HeLa cells were washed with PBS, fixed in PBS con-fragment in-frame with DNA encoding an N-terminal FLAG or myc
epitope in the vector pRK5. Deletion mutants of RIP were generated taining 2% paraformaldehyde, 0.2% glutaraldehyde for 5 min at 48C,
and washed again with PBS. Fixed cells were stained overnight withwith inserting polymerase chain reaction fragments encoding corre-
sponding RIP amino acid sequences in-frame with an N-terminal PBS containing 1 mg/ml X-Gal, 5 mM potassium ferricyanide, 5 mM
potassium ferrocyanide, 2 mM MgCl2, 0.02% NP-40, 0.01% SDS.myc epitope coding sequence in the vector pRK5. Expression plas-
mids encoding the alanine substitution mutants of the TRADD death The number of blue-staining cells were determined microscopically.
293 cells were analyzed for apoptosis by phase contrastmicroscopydomain (A. Park and V. B., unpublished data) and RIP(K45A) were
generated by polymerase chain reaction. 24 hr after transfection (Hsu et al., 1995).
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GenBank Accession Number
The GenBank accession number for the human RIP sequence re-
ported in this paper is U50062.
